COMMUNIQUÉS West-GlobeNewswire

Keryx Biopharmaceuticals Announces Publication of Data from the Phase 3 Trial of Auryxia® (ferric citrate) for Iron Deficiency Anemia in Patients with Chronic Kidney Disease, Not on Dialysis, in the American Journal of Hematology

04/04/2018 - 14:00

BOSTON, April 04, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced the [...]

Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg

04/04/2018 - 14:00

DANVERS, Mass., April 04, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD ), a leading provider of breakthrough heart recovery and support technologies, announced today that the Impella 5.5™ heart pump received CE [...]

Mustang Bio to Present at Biotech Innovations Conference

04/04/2018 - 14:00

NEW YORK, April 04, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a Fortress Biotech (NASDAQ: FBIO ) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]

Tauriga Sciences Inc. Increases its Stake in Crypto Currency Groestlcoin (Code: GRS); Company Now Holds 39,862 GRS Units

04/04/2018 - 13:59

NEW YORK, NY, April 04, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG ) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of [...]

VHA Home HealthCare Honours Outstanding Family Caregivers on National Carers Day

04/04/2018 - 13:36

TORONTO, April 04, 2018 (GLOBE NEWSWIRE) -- VHA Home HealthCare (VHA) honoured three caregiving heroes—Zulfikar Alladina of Toronto, Taylor Allen of Welland, and Madolina Sasa of Scarborough—who won this year’s Heart of [...]

Shire plc : Director Declaration

04/04/2018 - 13:01

Director Declaration April 4, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") announces that Susan Kilsby, Chairman of the Company, was appointed as a Non-Executive Director of Diageo plc on April 4, 2018. [...]

Cannabis Wheaton Announces Definitive Acquisition Agreement With Dosecann

04/04/2018 - 13:00

VANCOUVER, British Columbia, April 04, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX-V: CBW ) (" Cannabis Wheaton " or the " Company ") announces that it has entered into a definitive acquisition agreement [...]

Tonix Pharmaceuticals to Present FDA Breakthrough Therapy-Designated PTSD Program at the MicroCap Conference in New York

04/04/2018 - 13:00

First 50 Percent of Participants Enrolled in Phase 3 HONOR Study of Tonmya® (Cyclobenzaprine HCl Sublingual Tablets) for the Treatment of Military-Related PTSD Interim Results of HONOR Study Expected in Third Quarter [...]

Loxo Oncology Announces Acceptance of LOXO-292 Oral Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting

04/04/2018 - 12:45

STAMFORD, Conn., April 04, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq: LOXO ), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers [...]

Helius Medical Technologies, Inc. Announces Proposed Public Offering of Class A Common Stock and Warrants

04/04/2018 - 12:37

NEWTOWN, Pa., April 04, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX: HSM ) (OTCQB:HSDT) (“ Helius ” or the “ Company ”) announced today that it intends to offer and sell, subject to market conditions [...]

Global Autism Project Partners With Leading Technology and Behavioral Health Experts Rethink

04/04/2018 - 12:00

NEW YORK, April 04, 2018 (GLOBE NEWSWIRE) -- Global Autism Project is excited to announce their new partnership with leading technology and behavioral health experts, Rethink Behavioral Health. In this collaboration, [...]

Curetis' Unyvero BCU Blood Culture Application Receives Approval from Singapore Health Sciences Authority

04/04/2018 - 11:34

Curetis ' Unyvero BCU Blood Culture Application Receives Approval from Singapore Health Sciences Authority Second market authorization for Unyvero Cartridges this year in Singapore Amsterdam, the Netherlands, and [...]

Amarin Updates First Quarter Revenue Guidance, Reiterates Full Year Guidance and Updates on REDUCE-IT Cardiovascular Outcomes Study Progress and Vascepa® Promotion Initiatives

04/04/2018 - 11:15

Over 97% of Final Patient Visits in REDUCE-IT Completed or Scheduled for Near-Term Completion BEDMINSTER, N.J. and DUBLIN, Ireland, April 04, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a [...]

Amarin’s REDUCE-IT Cardiovascular Outcomes Study Reaches 100% Mark for Estimated Onset of Target Primary Major Adverse Cardiovascular Events

04/04/2018 - 11:00

On Track to Report REDUCE-IT Results Before the End of Q3 2018 BEDMINSTER, N.J., and DUBLIN, Ireland, April 04, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the [...]

Helsinn Group and Glenmark Pharmaceuticals enter into an exclusive licensing agreement for launch of AKYNZEO® in India and Nepal

04/04/2018 - 10:30

Helsinn Group and Glenmark Pharmaceuticals enter into an exclusive licensing agreement for launch of AKYNZEO® in India and Nepal AKYNZEO®, containing netupitant 300mg and palonosetron 0.5mg, is used for prevention of [...]

Curetis to Hold Investor Conference Call with Webcast on U.S. FDA De Novo Clearance of Unyvero System and Unyvero LRT Lower Respiratory Tract Infection Cartridge today

04/04/2018 - 10:06

Curetis to Hold Investor Conference Call with Webcast on U.S. FDA De Novo Clearance of Unyvero System and Unyvero LRT Lower Respiratory Tract Infection Cartridge today Amsterdam, the Netherlands, San Diego, CA, USA, and [...]

RefleXion Medical Raises $100 Million Series C to Commercialize Revolutionary Cancer Treatment

04/04/2018 - 09:01

World’s Only Biology-Guided Radiation Therapy Could Help Millions More Patients Worldwide HAYWARD, Calif., April 04, 2018 (GLOBE NEWSWIRE) -- RefleXion Medical, a medical technology company developing the first and only [...]

NOTICE OF BIOHIT OYJ’S ANNUAL GENERAL MEETING

04/04/2018 - 08:30

Biohit Oyj Stock Exchange Release April 4, 2018 at 9:30 am local time (EEST) Biohit Oyj shareholders are invited to attend the company’s Annual General Meeting to be held on Wednesday, April 25, 2018 starting at 5:00 pm [...]

CellaVision AB: Notice of 2018 Annual General Meeting of CellaVision (publ)

04/04/2018 - 08:21

The shareholders in CellaVision AB are hereby summoned to the Annual General Meeting, to be held on May 4, 2018 at 15.00 at CellaVision AB, Mobilvägen 12, Ideon in Lund, Sweden. Registration begins at 14:30. The [...]